Found: 36
Select item for more details and to access through your institution.
Sirtuins and Hypoxia in EMT Control.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 6, p. 737, doi. 10.3390/ph15060737
- By:
- Publication type:
- Article
Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
- Published in:
- Biochemical Journal, 2017, v. 474, n. 22, p. 3767, doi. 10.1042/BCJ20170541
- By:
- Publication type:
- Article
Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1217401
- By:
- Publication type:
- Article
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-00986-9
- By:
- Publication type:
- Article
Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective.
- Published in:
- Cell & Bioscience, 2023, v. 13, n. 1, p. 1, doi. 10.1186/s13578-023-00986-9
- By:
- Publication type:
- Article
Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Editorial: Novel Cancer Treatments Based on Autophagy Modulation.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Signaling, cancer cell plasticity, and intratumor heterogeneity.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01643-5
- By:
- Publication type:
- Article
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.
- Published in:
- Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-023-01462-0
- By:
- Publication type:
- Article
Retinoblastoma: present scenario and future challenges.
- Published in:
- Cell Communication & Signaling, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12964-023-01223-z
- By:
- Publication type:
- Article
Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 8, p. 894, doi. 10.3390/biom14080894
- By:
- Publication type:
- Article
Recent Advances on Mutant p53: Unveiling Novel Oncogenic Roles, Degradation Pathways, and Therapeutic Interventions.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 649, doi. 10.3390/biom14060649
- By:
- Publication type:
- Article
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 3, p. 361, doi. 10.3390/biom10030361
- By:
- Publication type:
- Article
Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.01141
- By:
- Publication type:
- Article
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 807, doi. 10.3390/cancers16040807
- By:
- Publication type:
- Article
Smart Modification on Magnetic Nanoparticles Dramatically Enhances Their Therapeutic Properties.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4095, doi. 10.3390/cancers13164095
- By:
- Publication type:
- Article
Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 25, doi. 10.3390/cancers12010025
- By:
- Publication type:
- Article
Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1415, doi. 10.3390/cancers11101415
- By:
- Publication type:
- Article
The impact of nanomaterials on autophagy across health and disease conditions.
- Published in:
- Cellular & Molecular Life Sciences, 2024, v. 81, n. 1, p. 1, doi. 10.1007/s00018-024-05199-y
- By:
- Publication type:
- Article
Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 7, p. 1215, doi. 10.1007/s00018-018-2973-y
- By:
- Publication type:
- Article
Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.607204
- By:
- Publication type:
- Article
Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1308362
- By:
- Publication type:
- Article
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2019, p. 1, doi. 10.1155/2019/8794612
- By:
- Publication type:
- Article
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2019, p. 1, doi. 10.1155/2019/1283075
- By:
- Publication type:
- Article
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O<sub>2-</sub>· production in cancer cells.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Water Soluble Iron-Based Coordination Trimers as Synergistic Adjuvants for Pancreatic Cancer.
- Published in:
- Antioxidants, 2021, v. 10, n. 1, p. 66, doi. 10.3390/antiox10010066
- By:
- Publication type:
- Article
Autophagy and the Lysosomal System in Cancer.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2752, doi. 10.3390/cells10102752
- By:
- Publication type:
- Article
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2015, v. 2015, p. 1, doi. 10.1155/2015/425708
- By:
- Publication type:
- Article
Boron Dipyrromethene (BODIPY) as Electron‐Withdrawing Group in Asymmetric Copper‐Catalyzed [3+2] Cycloadditions for the Synthesis of Pyrrolidine‐Based Biological Sensors.
- Published in:
- Advanced Synthesis & Catalysis, 2020, v. 362, n. 6, p. 1345, doi. 10.1002/adsc.201901465
- By:
- Publication type:
- Article
The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine.
- Published in:
- Molecules, 2020, v. 25, n. 1, p. 112, doi. 10.3390/molecules25010112
- By:
- Publication type:
- Article
Mutant p53 and mTOR/PKM2 regulation in cancer cells.
- Published in:
- IUBMB Life, 2016, v. 68, n. 9, p. 722, doi. 10.1002/iub.1534
- By:
- Publication type:
- Article
The metabolic landscape of cancer stem cells.
- Published in:
- IUBMB Life, 2015, v. 67, n. 9, p. 687, doi. 10.1002/iub.1426
- By:
- Publication type:
- Article
Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02497-w
- By:
- Publication type:
- Article
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 7, p. 1008, doi. 10.1016/j.molonc.2016.04.001
- By:
- Publication type:
- Article